Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression

NCT06510894 · clinicaltrials.gov ↗

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Cardiac Sarcoidosis

Interventions

DRUG: Sotagliflozin

Sponsor

University of Pennsylvania

Collaborators

[object Object]